Mark J Bulanda Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 22 hours ago
Mark J Bulanda has an estimated net worth of at least $26.4 million*, as of May 28, 2025. They own 215,825 shares of EMR stock. They have sold 4,574 shares of EMR stock since 2021, for an estimated $445,297.
Mark J Bulanda $EMR SEC Form 4 Insider Trading
Mark J Bulanda has filed a total of 1 insider trades in $EMR since 2021. Their most recent trade was a sale of 4,574 shares, made on Mar 29, 2022. Their largest trade was a sale of 4,574 shares, made on Mar 29, 2022. We estimate that they now own 215,825 shares of $EMR, worth an estimated $26.0 million.
Insider Trading at $EMR
There have been a total of 25 insider trades reported at $EMR since 2021, with 24,400 shares purchased and 315,993 shares sold. The most active insider traders in $EMR stock have been Surendralal Lanca Karsanbhai, Frank J Dellaquila, and Michael H. Train. The most recent trade was a sale of 28,305 shares reported by Michael H. Train (SVP & Chief Sustain Officer), made on May 12, 2025.
History of Insider Stock Trades by Mark J Bulanda
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 4,574 | Mar 29, 2022 | March 31, 2022, 4:19 p.m. |
$EMR Executives and Stock Owners with Insider Trades
-
Surendralal Lanca Karsanbhai, President & CEO
-
Frank J Dellaquila, Senior Exec. VP and CFO
-
Michael H. Train, SVP & Chief Sustain Officer
-
Surendralal Lanca Karsanbhai, CEO and President
-
Bell Katherine Button, Sr. VP & Chief Marketing Off.
-
Lisa Flavin, Senior VP & CCO
-
Mark J Bulanda, Exec Pres Auto Sols
-
Nicholas J. Piazza, Senior VP & CPO
-
Ram R. Krishnan, Executive Vice Pres & COO
-
Sara Yang Bosco, Sr. VP, Secy and Gen. Counsel
-
Vidya Ramnath, Senior VP & CMO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.